Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Applying to Rutgers Cancer Institute of New Jersey · New Brunswick, New Jersey
Answer a few short questions to share with the research team.